Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-6-11
|
pubmed:abstractText |
Blockade of the renin-angiotensin system was studied in male Sprague-Dawley rats during long-term inhibition of nitric oxide synthase. Nitro-L-arginine-methyl ester (L-NAME) was placed in the drinking water for 4 weeks (approximately 100 mg/kg per day). Separate groups of rats were coadministered the angiotensin II antagonist A-81988 in the drinking water ranging from approximately 0.001 to 1 mg/kg per day. Control groups received only tap water or A-81988 alone. Each week, rats were placed in metabolic cages, and tail-cuff blood pressures and blood samples were taken. L-NAME produced a sustained elevation in tail-cuff pressure that was completely prevented by A-81988. No changes in creatinine clearance, sodium excretion, plasma creatinine concentration, or blood urea nitrogen were observed. Food and water intakes were identical in all groups. Water excretion was significantly increased in L-NAME-treated animals regardless of additional inhibitor treatment, suggesting a possible role for nitric oxide synthase in the control of water excretion; this effect was independent of blood pressure. Although less potent than A-81988, the angiotensin II antagonist losartan and the angiotensin converting enzyme inhibitor enalapril also blocked L-NAME-induced hypertension. In a separate series of experiments, rats were not given A-81988 until 2 weeks after hypertension had fully developed in L-NAME-treated rats. Within 1 week of treatment with the angiotensin II antagonist, tail-cuff pressure returned to normal. We conclude from these studies that long-term inhibition of endogenous nitric oxide production produces an angiotensin II-dependent form of hypertension.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acid Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Nicotinic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0194-911X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
660-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7684026-Amino Acid Oxidoreductases,
pubmed-meshheading:7684026-Angiotensin II,
pubmed-meshheading:7684026-Animals,
pubmed-meshheading:7684026-Arginine,
pubmed-meshheading:7684026-Diuresis,
pubmed-meshheading:7684026-Dose-Response Relationship, Drug,
pubmed-meshheading:7684026-Hypertension,
pubmed-meshheading:7684026-Male,
pubmed-meshheading:7684026-Nicotinic Acids,
pubmed-meshheading:7684026-Nitric Oxide Synthase,
pubmed-meshheading:7684026-Nitroarginine,
pubmed-meshheading:7684026-Proteinuria,
pubmed-meshheading:7684026-Pyridines,
pubmed-meshheading:7684026-Rats,
pubmed-meshheading:7684026-Rats, Sprague-Dawley,
pubmed-meshheading:7684026-Renin,
pubmed-meshheading:7684026-Tetrazoles,
pubmed-meshheading:7684026-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
|
pubmed:affiliation |
Abbott Laboratories, Abbott Park, IL 60064.
|
pubmed:publicationType |
Journal Article
|